Safety profile of CAP7.1 obtained during Phase I Trial in adult patients with refractory malignancies

    January 2016 in “ Refubium (Universitätsbibliothek der Freien Universität Berlin) ”
    P. Mehlitz

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →